Hendrik Peter Scholl

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Zug
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Hendrik Peter Scholl
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Hendrik Peter Scholl

Form 4 holding Chief Medical Officer

BELITE BIO, INC

Security class
American depositary share
Shares / value
15,000
Estimated value
$2,206,650
Report date
18 Jun 2026
Price
$147.11
Ownership
By Bioptima Ltd.
Form 4 holding Chief Medical Officer

BELITE BIO, INC

Security class
Stock Option (right to buy)
Shares / value
10,000
Estimated value
Report date
21 Apr 2026
Price
Ownership
By Bioptima Ltd.
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Hendrik Peter Scholl

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .